Change in Glycemic Control With Use of a Digital Therapeutic in Adults With Type 2 Diabetes: Cohort Study

BACKGROUND: Intensive lifestyle change can treat and even reverse type 2 diabetes. Digital therapeutics have the potential to deliver lifestyle as medicine for diabetes at scale. OBJECTIVE: This 12-week study investigates the effects of a novel digital therapeutic, FareWell, on hemoglobin A(1c) (HbA...

Descripción completa

Detalles Bibliográficos
Autores principales: Berman, Mark A, Guthrie, Nicole L, Edwards, Katherine L, Appelbaum, Kevin J, Njike, Valentine Y, Eisenberg, David M, Katz, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238888/
https://www.ncbi.nlm.nih.gov/pubmed/30291074
http://dx.doi.org/10.2196/diabetes.9591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238888/
https://www.ncbi.nlm.nih.gov/pubmed/30291074
http://dx.doi.org/10.2196/diabetes.9591

Ejemplares similares